RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$339M
1-Year Return
24.9%
This Quarter Return
+10.11%
1 Year Return
+24.9%
3 Year Return
+114.14%
5 Year Return
+206.87%
10 Year Return
–
AUM
$193M
AUM Growth
+$36M
(+23%)
Cap. Flow
+$20.4M
Cap. Flow
% of AUM
10.55%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
201
New
32
Increased
82
Reduced
70
Closed
11
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$4.69M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$2.95M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
$2.56M |
| 4 |
Deere & Co
DE
|
$1.43M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$1.39M |
Top Sells
| 1 |
Diamondback Energy
FANG
|
$1.24M |
| 2 |
Molina Healthcare
MOH
|
$1.08M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
$1.01M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$981K |
| 5 |
Microsoft
MSFT
|
$911K |
Sector Composition
| 1 | Technology | 15.35% |
| 2 | Healthcare | 14.12% |
| 3 | Financials | 8.85% |
| 4 | Consumer Staples | 7.04% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nasdaq
NDAQ
$54B
| $1.69M | 0.87% |
26,689
+295
| +1% | +$18.7K |
|
27
iShares Core S&P 500 ETF
IVV
$665B
| $1.65M | 0.86% |
4,137
+406
| +11% | +$162K |
|
28
BioMarin Pharmaceuticals
BMRN
$10.8B
| $1.64M | 0.85% |
14,637
+2,256
| +18% | +$252K |
|
29
JPMorgan Chase
JPM
$836B
| $1.63M | 0.84% |
11,560
+761
| +7% | +$107K |
|
30
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $1.56M | 0.8% |
11,536
-423
| -4% | -$57K |
|
|
ETW
31
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$976M
| $1.53M | 0.79% |
187,108
-571
| -0.3% | -$4.66K |
|
32
Boeing
BA
$175B
| $1.52M | 0.79% |
7,212
+5,477
| +316% | +$1.16M |
|
|
IGR
33
CBRE Global Real Estate Income Fund
IGR
$700M
| $1.51M | 0.78% |
232,134
+62
| +0% | +$403 |
|
34
Palo Alto Networks
PANW
$129B
| $1.48M | 0.77% |
20,852
+186
| +0.9% | +$13.2K |
|
35
Lowe's Companies
LOW
$148B
| $1.47M | 0.76% |
7,002
-133
| -2% | -$27.9K |
|
36
Bristol-Myers Squibb
BMY
$95.5B
| $1.46M | 0.76% |
20,234
-56
| -0.3% | -$4.05K |
|
37
Merck
MRK
$210B
| $1.39M | 0.72% |
12,600
+1,074
| +9% | +$119K |
|
|
38
Vanguard FTSE All-World ex-US ETF
VEU
$48.5B
| $1.39M | 0.72% |
+25,745
| New | +$1.39M |
|
39
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $1.38M | 0.72% |
18,882
+77
| +0.4% | +$5.65K |
|
40
Valero Energy
VLO
$48.4B
| $1.37M | 0.71% |
9,957
+397
| +4% | +$54.6K |
|
41
Oracle
ORCL
$626B
| $1.35M | 0.7% |
15,284
-220
| -1% | -$19.5K |
|
42
Array Technologies
ARRY
$1.38B
| $1.33M | 0.69% |
56,303
+17,917
| +47% | +$423K |
|
43
Abbott
ABT
$231B
| $1.32M | 0.68% |
11,633
-573
| -5% | -$65K |
|
44
Schwab US Dividend Equity ETF
SCHD
$72B
| $1.3M | 0.67% |
50,502
+21,672
| +75% | +$557K |
|
45
Humana
HUM
$37.5B
| $1.3M | 0.67% |
2,646
-451
| -15% | -$221K |
|
46
Neurocrine Biosciences
NBIX
$13.8B
| $1.28M | 0.66% |
11,864
+1,305
| +12% | +$141K |
|
47
Ameren
AEE
$27.2B
| $1.28M | 0.66% |
14,291
+45
| +0.3% | +$4.02K |
|
48
Emerson Electric
EMR
$74.6B
| $1.27M | 0.66% |
13,887
+1,000
| +8% | +$91.2K |
|
|
EOS
49
Eaton Vance Enhance Equity Income Fund II
EOS
$1.28B
| $1.24M | 0.64% |
73,900
+3,228
| +5% | +$54K |
|
50
Ulta Beauty
ULTA
$23.6B
| $1.22M | 0.63% |
+2,459
| New | +$1.22M |
|